Airborne PFA and FTS Detection Using Online SPE-LC–HRMS
Researchers have developed and validated a sensitive analytical method for the determination of 16 polyfluorinated alkyl substances (PFAS) in fine airborne particulate matter (PM2.5) using online solid‑phase extraction (SPE) coupled with liquid chromatography (LC)–negative electrospray ionization high resolution mass spectrometry (−) (ESI-HRMS) (1).
There is great concern over PM2.5, as these small particles can penetrate deep into respiratory systems, leading to cardiovascular and respiratory diseases as well as lung cancer. The World Health Organization (WHO) provides guideline values for PM2.5. However, PM2.5 mass concentration alone is not indicative of the risks from exposure to fine particles, as the toxicity of those particles is not accounted for. They are chemically complex and the typical composition of ambient PM2.5 particles contains thousands of individual organic compounds that can be extremely toxic, even when present at low concentrations. PFAS are one such class of contaminant to be concerned about in this regard. They were widely used in a broad range of consumer products and industrial applications for decades, and persist within an environmental context for a long time—even gaining notoriety as “forever chemicals”. Their use has been phased out in many countries, with less toxic alternatives replacing them; however, even these replacements, such as fluorotelomer sulfonates (FTS), have been found to persist in the environment, and there is emerging evidence that their impact on human health is similar to that of banned PFAS.
The analysis of PFAS in environmental samples is challenging because of trace‑level concentrations requiring highly sensitive analytical methods. Currently, only a few publications have reported analytical methods for the identification of PFAS in atmospheric samples; however, there are issues surrounding these methods, such as interference from matrix effects. As such, researchers aimed to develop a sensitive online SPE-LC–HRMS technique for the analysis of PFAS in atmospheric aerosol particles that would not only eliminate issues from previous methodologies but also expand the analyte detection range for 4:2 and 8:2 FTS’s, and utilize the developed method to analyze ambient PM2.5 samples collected in urban environments.
Results indicated that the developed method provided limits of detection (LODs) in the range 0.08–0.5 pg/mL of sample extract. This enabled detection of selected PFAS in aerosol particles at low fg/m3 levels, with a high tolerance to the considered PM matrix. When applied to the analysis of PFAS collected at two urban locations in Ireland, the method found several PFAS above the detection limit as well as FTS’s. The detection of PFAS in the environment despite them being phased out from productions in the European Union (EU) two decades ago only highlights their ability to remain in the environment for long periods of time. The detection of FTS’s also raises concerns about their suitability as alternatives to PFAS, with their potential impact on human health and environmental well-being yet to be fully explored.
Reference
- I. Kourtchev et al., Sci. Total Environ. 835, 155496 (2022).
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.
